Venturi Wealth Management LLC Raises Stock Holdings in Certara, Inc. (NASDAQ:CERT)

Venturi Wealth Management LLC increased its holdings in Certara, Inc. (NASDAQ:CERT) by 839.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,808 shares of the company’s stock after acquiring an additional 2,509 shares during the quarter. Venturi Wealth Management LLC’s holdings in Certara were worth $30,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CERT. Blue Trust Inc. grew its position in Certara by 20.9% during the 4th quarter. Blue Trust Inc. now owns 4,747 shares of the company’s stock worth $56,000 after purchasing an additional 822 shares during the last quarter. Nicolet Advisory Services LLC boosted its stake in shares of Certara by 6.6% during the third quarter. Nicolet Advisory Services LLC now owns 24,831 shares of the company’s stock worth $273,000 after buying an additional 1,531 shares during the period. KBC Group NV grew its holdings in shares of Certara by 48.2% during the third quarter. KBC Group NV now owns 4,873 shares of the company’s stock worth $57,000 after buying an additional 1,584 shares during the last quarter. Harbor Capital Advisors Inc. increased its position in Certara by 18.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 20,144 shares of the company’s stock valued at $236,000 after acquiring an additional 3,136 shares during the period. Finally, Atria Investments Inc raised its stake in Certara by 21.6% during the 3rd quarter. Atria Investments Inc now owns 19,743 shares of the company’s stock valued at $231,000 after acquiring an additional 3,501 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CERT shares. Barclays lowered their target price on Certara from $14.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 7th. Robert W. Baird dropped their price objective on shares of Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Six investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Certara currently has an average rating of “Hold” and an average target price of $15.92.

Certara Stock Down 1.4 %

Shares of NASDAQ:CERT opened at $12.38 on Wednesday. Certara, Inc. has a 12-month low of $9.41 and a 12-month high of $19.87. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.28. The stock’s 50-day moving average price is $12.36 and its two-hundred day moving average price is $11.63. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of -61.90, a PEG ratio of 9.29 and a beta of 1.57.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.